Search clinical trials for: neurofibromatosis,
Total 247 results
-
Guy's and St Thomas' NHS Foundation TrustCompletedNeurofibromatosis 1, NF1United Kingdom
-
Guy's and St Thomas' NHS Foundation TrustCompletedNeurofibromatosis 2United Kingdom
-
Novartis PharmaceuticalsTerminatedMalignant Peripheral Nerve Sheath TumorsGermany
-
The Children's Tumor FoundationRecruitingNeurofibromatosis 1 | Neurofibromatosis 2 | SchwannomatosisUnited States
-
Massachusetts General HospitalUnited States Department of Defense; AstraZenecaCompletedMeningioma | Neurofibromatosis 2United States
-
John Jay High SchoolUnknownNeurofibromatosis Type 1United States
-
Nicholas GulatiCompleted
-
Recursion Pharmaceuticals Inc.RecruitingNeurofibromatosis Type 2United States
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Children's Hospital of Philadelphia; Washington... and other collaboratorsCompletedNeurofibromatosis Type 1United States, Australia
-
Assistance Publique - Hôpitaux de ParisFrench National Referral Center for NeurofibromatosesUnknown
-
Virginia Commonwealth UniversityCompletedNeurofibromatosis 1 | Neurocognitive Deficit | Mental Health ImpairmentUnited States
-
National Institute of Neurological Disorders and...CompletedNeoplasms | Vestibular Disease | Nervous System DiseaseUnited States
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis Type 1United States, Spain, Poland, Russian Federation
-
Washington University School of MedicineCompleted
-
University of Texas Southwestern Medical CenterWithdrawnPeripheral Nerve TumorsUnited States
-
Massachusetts General HospitalJohns Hopkins UniversityActive, not recruitingCutaneous NeurofibromaUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Children's Hospital of Philadelphia; Washington... and other collaboratorsCompletedNeurofibromatosis Type 1United States
-
ItalfarmacoTerminatedChronic Lymphocytic LeukemiaItaly
-
Shriners Hospitals for ChildrenUniversity of Utah; Thrasher Research FundCompletedNeurofibromatosis Type 1United States
-
Shriners Hospitals for ChildrenUniversity of UtahCompletedNeurofibromatosis Type 1 | Tibial DysplasiaUnited States
-
Johns Hopkins UniversityNeurofibromatosis Therapeutic Acceleration ProgramRecruitingCutaneous Neurofibroma | NF1 | MonotherapyUnited States
-
Johns Hopkins UniversityNeurofibromatosis Therapeutic Acceleration ProgramRecruitingNeurofibromatosis 1 | Neurofibromatosis Type 1 | Cutaneous Neurofibroma | Neurofibromatosis (Nonmalignant)United States
-
SpringWorks Therapeutics, Inc.Active, not recruitingPlexiform Neurofibroma | Neurofibromatosis Type 1 (NF1)United States
-
University of MinnesotaMayo Clinic; Columbia University; University of Utah; Texas Scottish Rite Hospital... and other collaboratorsCompleted
-
University of Alabama at BirminghamPacific Pediatric Neuro-Oncology Consortium; Array BioPharmaActive, not recruitingNeurofibromatosis Type 1 | Plexiform NeurofibromaUnited States
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
Children's Hospital of PhiladelphiaCompletedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
Children's Hospital of PhiladelphiaTerminatedNeurofibromatosis Type 1 | Precancerous ConditionUnited States
-
National Cancer Institute (NCI)WithdrawnNeoplasms, Nerve Tissue | Peripheral Nervous System Diseases | Heredodegenerative Disorders, Nervous System | Neurofibromatosis 1
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States
-
Donald BaselRecruiting
-
University of UtahUniversity of British Columbia; Children's Hospital Medical Center, Cincinnati and other collaboratorsTerminatedNeurofibromatosis Type 1 (NF1)United States, Canada
-
National Cancer Institute (NCI)CompletedPlexiform Neurofibroma | Neurofibromatosis Type IUnited States
-
Novartis PharmaceuticalsTerminatedPlexiform Neurofibroma Associated With Neurofibromatosis Type 1Israel
-
SpringWorks Therapeutics, Inc.AvailableNeurofibromatosis Type 1-Associated Plexiform Neurofibromas | Histiocytic Neoplasm | Other MAP-K Pathway Driven Diseases
-
University of California, Los AngelesCompletedNeurofibromatosis 1United States
-
University of Alabama at BirminghamCompletedNeurofibromatosis Type 1 and Growing or Symptomatic, Inoperable PNUnited States
-
AstraZenecaCompletedHealthy Participants | Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)United States
-
University of Alabama at BirminghamGenentech, Inc.CompletedNeurofibromatosis Type 2 | Progressive Vestibular SchwannomasUnited States
-
PTC TherapeuticsUnited States Department of DefenseTerminated
-
The University of Texas Health Science Center,...Society for Pediatric DermatologyCompletedTuberous Sclerosis | Neurofibromatoses | Neurofibroma | AngiofibromaUnited States
-
Massachusetts General HospitalCompletedNeurofibromatosis Type 1 | Cutaneous NeurofibromasUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Washington University School of MedicineSt. Louis Children's HospitalTerminated
-
Washington University School of MedicineCompletedNeurofibromatosis Type 1 | Pediatric Brain TumorUnited States
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
University of UtahNational Institute of Neurological Disorders and Stroke (NINDS)CompletedNeurofibromatosis Type 1United States
-
NYU Langone HealthNovartis Pharmaceuticals; The Children's Tumor FoundationCompletedNeurofibromatosis Type IIUnited States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsTerminatedNeuroma, Acoustic | Neurofibromatosis Type 2United States